Plus Therapeutics Announces New Employment Inducement Grants
The Company agreed to grant these equity awards to Mr. Huang to induce him to commence employment with the Company.
- The Company agreed to grant these equity awards to Mr. Huang to induce him to commence employment with the Company.
- The approved option awards are options to purchase up to 5,000 shares of the common stock of the Company.
- The exercise price of the options is equal to the closing price of the Company’s common stock on May 8, 2024, the grant date.
- The Company believes that these equity grants create a strong alignment of interests between Mr. Huang and Company shareholders.